These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8318022)

  • 21. Conformational study of angiotensin II.
    Shin YA; Yoo SE
    Biopolymers; 1996 Feb; 38(2):183-90. PubMed ID: 8589252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of lysine side chain length on intra-helical glutamate--lysine ion pairing interactions.
    Cheng RP; Girinath P; Ahmad R
    Biochemistry; 2007 Sep; 46(37):10528-37. PubMed ID: 17718542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Structuro-functional organization of delta sleep-inducing peptide].
    Akhmenov NA; Abbasly PM; Popov EM
    Mol Biol (Mosk); 1989; 23(3):676-82. PubMed ID: 2770737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the conformational domains of bradykinin by computational methods.
    Perez JJ; Sanchez YM; Centeno NB
    J Pept Sci; 1995; 1(4):227-35. PubMed ID: 9223000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A method to configure protein side-chains from the main-chain trace in homology modelling.
    Eisenmenger F; Argos P; Abagyan R
    J Mol Biol; 1993 Jun; 231(3):849-60. PubMed ID: 8515455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Free energy landscapes of peptides by enhanced conformational sampling.
    Nakajima N; Higo J; Kidera A; Nakamura H
    J Mol Biol; 2000 Feb; 296(1):197-216. PubMed ID: 10656827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-dimensional solution structure of mu-conotoxin GIIIB, a specific blocker of skeletal muscle sodium channels.
    Hill JM; Alewood PF; Craik DJ
    Biochemistry; 1996 Jul; 35(27):8824-35. PubMed ID: 8688418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformation-function relationships in LHRH analogs. II. Conformations of LHRH peptide agonists and antagonists.
    Nikiforovich GV; Marshall GR
    Int J Pept Protein Res; 1993 Aug; 42(2):181-93. PubMed ID: 8407112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structure-function organization of neurokinin A and neurokinin B molecules. I. Theoretical conformational analysis of neurokinin A].
    Agaeva GA; Kerimli NN; Godzhaev NM
    Biofizika; 2005; 50(2):203-14. PubMed ID: 15856976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy and reliability of the scaling-relaxation method for loop closure: an evaluation based on extensive and multiple copy conformational samplings.
    Zheng Q; Kyle DJ
    Proteins; 1996 Feb; 24(2):209-17. PubMed ID: 8820487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural energetics of peptide recognition: angiotensin II/antibody binding.
    Murphy KP; Xie D; Garcia KC; Amzel LM; Freire E
    Proteins; 1993 Feb; 15(2):113-20. PubMed ID: 8441749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of the structure of lipid vesicle-bound angiotensin II and angiotensin I.
    Jalili PR; Dass C
    Anal Biochem; 2008 Mar; 374(2):346-57. PubMed ID: 18162166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The beta-turn scaffold of tripeptide containing an azaphenylalanine residue.
    Lee HJ; Park HM; Lee KB
    Biophys Chem; 2007 Jan; 125(1):117-26. PubMed ID: 16890344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin.
    Jørgensen AM; Olsen HB; Balschmidt P; Led JJ
    J Mol Biol; 1996 Apr; 257(3):684-99. PubMed ID: 8648633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of conformational isomerism in alpha-melanocyte stimulating hormone by design of cyclic analogues.
    Nikiforovich GV; Sharma SD; Hadley ME; Hruby VJ
    Biopolymers; 1998 Sep; 46(3):155-67. PubMed ID: 9699465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists.
    Rosenström U; Sköld C; Plouffe B; Beaudry H; Lindeberg G; Botros M; Nyberg F; Wolf G; Karlén A; Gallo-Payet N; Hallberg A
    J Med Chem; 2005 Jun; 48(12):4009-24. PubMed ID: 15943474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization by NMR and molecular modeling of the binding of polyisoprenols and polyisoprenyl recognition sequence peptides: 3D structure of the complexes reveals sites of specific interactions.
    Zhou GP; Troy FA
    Glycobiology; 2003 Feb; 13(2):51-71. PubMed ID: 12626407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid refinement of protein interfaces incorporating solvation: application to the docking problem.
    Jackson RM; Gabb HA; Sternberg MJ
    J Mol Biol; 1998 Feb; 276(1):265-85. PubMed ID: 9514726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling conformational changes in cyclosporin A.
    O'Donohue MF; Burgess AW; Walkinshaw MD; Treutlein HR
    Protein Sci; 1995 Oct; 4(10):2191-202. PubMed ID: 8535256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calculating proton uptake/release and binding free energy taking into account ionization and conformation changes induced by protein-inhibitor association: application to plasmepsin, cathepsin D and endothiapepsin-pepstatin complexes.
    Alexov E
    Proteins; 2004 Aug; 56(3):572-84. PubMed ID: 15229889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.